Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles-Reference-Cited by-同舟云学术

Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles

Published:2022-03 Issue: Volume:343 Page:207-216
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Evers Martijn J.W.,Du Wenjuan,Yang Qiangbing,Kooijmans Sander A.A.,Vink Aryan,van Steenbergen Mies,Vader Pieter,de Jager Saskia C.A.,Fuchs Sabine A.,Mastrobattista Enrico,Sluijter Joost P.G.,Lei Zhiyong,Schiffelers Raymond

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference50 articles.

1. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America;Yancy;J. Am. Coll. Cardiol.,2017

2. Heart regeneration;Laflamme;Nature,2011

3. Cellular and molecular mechanism of cardiac regeneration: a comparison of newts;de Wit;Zebrafish Mammals Biomol.,2020

4. Repairing the heart: state-of the art delivery strategies for biological therapeutics;Yang;Adv. Drug Deliv. Rev.,2020

5. Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model;Lin;Circ. Res.,2014

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic nanoplatform treats myocardial ischemia/reperfusion injury by synergistically promoting angiogenesis and inhibiting inflammation;Colloids and Surfaces B: Biointerfaces;2024-11

2. Myocardium-targeted liposomal delivery of the antioxidant peptide 8P against doxorubicin-induced myocardial injury;International Journal of Pharmaceutics;2024-09

3. Lipid Nanoparticles for Nucleic Acid Delivery Beyond the Liver;Human Gene Therapy;2024-08-28

4. Gene Therapy for Inherited Arrhythmia Syndromes;Cardiogenetics;2024-08-02

5. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy;Journal of Controlled Release;2024-08